Information Provided By: 
Fly News Breaks for June 17, 2019
ARRY
Jun 17, 2019 | 09:19 EDT
SunTrust analyst Peter Lawson downgraded Array BioPharma (ARRY) to Hold from Buy and raised his price target on the stock to $48 from $32 to account for the company's agreement to be acquired by Pfizer (PFE).
News For ARRY From the Last 2 Days
ARRY
Apr 24, 2024 | 11:02 EDT
Wells Fargo notes that a group of seven domestic solar product makers, including First Solar (FSLR), filed a petition to levy anti-dumping and countervailing duties on solar imports from Cambodia, Malaysia, Thailand and Vietnam, looking for duties ranging from 70.4% to 271.5%. The firm, which included the "important reminder" that "this is just a petition," says the uncertainty created by the petition is "incrementally positive" for First Solar and negative for Canadian Solar (CSIQ), Array Technologies (ARRY) and Nextracker (NXT).
